ライフサイエンスコーパス: nonagenarian

1 idity in individuals ranging from newborn to nonagenarian.

2 ilar mortality outcomes in octogenarians and nonagenarians.

3 ement in the quality of aging in a cohort of nonagenarians.

4 5 plasma proteins from 4,263 young adults to nonagenarians (18-95 years old) and developed a new bioi

5 educing inequalities, with octogenarians and nonagenarians accounting for most deaths in countries wi

6 One-year mortality for octogenarians and nonagenarians after dialysis initiation was 46%.

7 tality rates were significantly higher among nonagenarians (age >/=90 years vs. <90 years: 30-day: 8.

8 rce on outcomes of pacemaker implantation in nonagenarians (age>/=90 years).

9 Cardiac arrest in nonagenarian and centenarian ICU patients carries high m

10 capita health expenditure in octogenarians, nonagenarians and centenarians in the Colombian populati

11 In this large population of nonagenarians and centenarians with NSTE-ACS, increasing

12 late-onset AD should target the families of nonagenarians and centenarians.

13 erly, the absolute rates are modest, even in nonagenarians, and comorbidity is a stronger predictor.

14 proves quality of life to the same degree in nonagenarians as in younger patients.

15 We used nonagenarians as the comparison group with adjustment fo

16 in the crossroad between the newborn and the nonagenarian/centenarian groups.

17 prevalence of a Ruminococcus gnavus clade in nonagenarians correlated with distinct plasma bile acid

18 However, nonagenarians had a higher mean Society of Thoracic Surg

19 Nonagenarians had lower (worse) median Kansas City Cardi

20 plasty for centenarians were higher than for nonagenarians (hazard ratio 1.46, 95% confidence interva

21 The number of octogenarians and nonagenarians initiating dialysis has increased consider

22 Compared with octogenarians and nonagenarians initiating dialysis in 1996, those startin

23 ed following genomic DNA extraction from 150 nonagenarians living in the LBZ and 150 controls from a

24 omes of endovascular aortic repair (EVAR) in nonagenarians (NAs) with non-nonagenarians (NNAs).

25 epair (EVAR) in nonagenarians (NAs) with non-nonagenarians (NNAs).

26 thyroidectomy to be safe in octogenarian and nonagenarian patients with primary hyperparathyroidism.

27 More than 20% and 30% of octogenarians and nonagenarians, respectively, have vascular disease in at

28 the study to a larger cohort of newborn and nonagenarian samples using a 450,000 CpG-site DNA methyl

29 offspring of nonagenarians with at least one nonagenarian sibling have increased TSH secretion but si

30 Both middle-aged to elderly offspring of nonagenarian siblings and control subjects show common a

31 tal, 185 middle-aged to elderly offspring of nonagenarian siblings, who were enriched for familial fa

32 The number of octogenarians and nonagenarians starting dialysis increased from 7054 pers

33 In addition, among VF performed by nonagenarians, tests performed in the afternoon were ass

34 of this study was to compare the outcomes of nonagenarians to younger patients undergoing TAVR in cur

35 The corresponding figures for nonagenarians were 33,975 and 2,050, respectively.

36 157 octogenarians and nonagenarians who initially received a pacemaker between

37 We report that offspring of nonagenarians with at least one nonagenarian sibling hav

38 urvived COVID-19 more than octogenarians and nonagenarians, with several hypotheses attributing this

39 ormal relative survival in octogenarians and nonagenarians without heart disease is reassuring; the p